Physician profile
Atta Bader
NPI 1144583550
$9,068.69
in general payments reported to CMS, 2019-2025
8 companies · $124 in 2025
The $124 reported for 2025 was more than what a typical Dentist provider received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $230 · 2020: $209 · 2021: $141 · 2022: $3,799 · 2023: $226 · 2024: $4,340 · 2025: $124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $4,050 · Food and Beverage: $602 · Entertainment: $38.47.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $4,050.00 |
| Food and Beverage | $601.69 |
| Entertainment | $38.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $8,278.16 | 2019-2025 | Itero Element 5d Plus Lite, Cart Configuration, Invisalign System - Moderate, Invisalign |
| Biohorizons Implant Systems INC. | $366.08 | 2019-2025 | Biohorizons, Biohorizons Dental Implants |
| Kulzer, LLC | $258.46 | 2024 | |
| Biolase, INC. | $82.80 | 2020-2022 | |
| Straumann USA LLC | $38.47 | 2023 | |
| Ultradent Products INC | $20.44 | 2021 | |
| Colgate Oral Pharmaceuticals, INC. | $14.82 | 2025 | |
| Voco America INC. | $9.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Atta Bader listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.